Common-Size Income Statement
Quarterly Data
Based on: 10-Q (reporting date: 2026-09-30), 10-Q (reporting date: 2026-06-30), 10-Q (reporting date: 2026-03-31), 10-K (reporting date: 2025-12-31), 10-Q (reporting date: 2025-09-30), 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31).
The financial trajectory over the observed period is characterized by a significant expansion in profitability margins and an increase in operating leverage. Revenue efficiency has improved consistently, with a marked transition from moderate margins in 2021 to substantially higher profitability levels by 2026.
- Gross Margin Expansion
- A consistent upward trend is observed in gross margins, which rose from 72.40% in March 2021 to a peak of 85.78% by March 2026. This expansion is mirrored by a corresponding decline in the cost of sales, which decreased from 27.60% to 16.12% over the period. This suggests an increase in production efficiency, pricing power, or a shift toward higher-margin product mixes.
- Operating Expense Optimization
- Both Research and Development (R&D) and Marketing, Selling, and Administrative (SG&A) expenses show a general downward trend as a percentage of revenue. R&D expenditures fluctuated between 20% and 28% until 2024, subsequently declining to approximately 17% by September 2026. SG&A expenses followed a similar trajectory, decreasing from a range of 20% to 25% in the early period to 12.81% by the end of the series. This indicates that revenue growth is scaling faster than the associated operational costs.
- Strategic Investment Volatility
- The impact of acquired in-process research and development (IPRD) is characterized by high volatility and periodic spikes. Notable increases occurred in September 2023 (-31.32%), September 2024 (-24.71%), and during the middle of 2026. These spikes frequently coincide with temporary contractions in quarterly operating income, reflecting the cost of strategic acquisitions used to bolster the long-term pipeline.
- Operating and Net Income Performance
- Operating income margins exhibit a strong overall growth trend, rising from 16.98% in March 2021 to peaks exceeding 45% in 2025, despite the aforementioned volatility from IPRD and special charges. Net income margins followed a similar positive trajectory, starting at 19.91% and reaching a high of 37.36% in March 2026. This growth in the bottom line is partially offset by an increase in the effective tax rate as a percentage of revenue, which grew from roughly 1.78% in early 2021 to between 8% and 9% in 2025 and 2026, likely reflecting the impact of higher taxable income.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?